Day: October 2, 2021

Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells.

Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells.

PMID:  Cancer Lett. 2015 Feb 1 ;357(1):393-403. Epub 2014 Nov 27. PMID: 25434800 Abstract Title:  Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells. Abstract:  The important goal of cancer drug discovery is to develop therapeutic agents that are effective, safe, and affordable. In the present study, we demonstrated that alantolactone,…

Close
Menu